2.33
price up icon9.91%   0.21
after-market Handel nachbörslich: 2.31 -0.02 -0.86%
loading
Schlusskurs vom Vortag:
$2.12
Offen:
$2.08
24-Stunden-Volumen:
399.67K
Relative Volume:
1.02
Marktkapitalisierung:
$141.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.86M
KGV:
-2.0804
EPS:
-1.12
Netto-Cashflow:
$-55.66M
1W Leistung:
+23.94%
1M Leistung:
+76.52%
6M Leistung:
+111.82%
1J Leistung:
-0.85%
1-Tages-Spanne:
Value
$2.01
$2.35
1-Wochen-Bereich:
Value
$1.86
$2.35
52-Wochen-Spanne:
Value
$0.8551
$3.36

Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile

Name
Firmenname
Acumen Pharmaceuticals Inc
Name
Telefon
617-344-4190
Name
Adresse
1210-1220 WASHINGTON STREET, NEWTON
Name
Mitarbeiter
52
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
ABOS's Discussions on Twitter

Vergleichen Sie ABOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ABOS
Acumen Pharmaceuticals Inc
2.33 128.42M 0 -64.86M -55.66M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
412.22 104.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
469.36 60.95B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.60 59.11B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
812.95 49.23B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
320.94 35.92B 4.56B -176.77M 225.30M -1.7177

Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-17 Eingeleitet Citigroup Buy
2024-07-26 Eingeleitet Citigroup Buy
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-07-20 Fortgesetzt BofA Securities Buy
2023-05-18 Eingeleitet Cantor Fitzgerald Overweight
2022-07-15 Eingeleitet BTIG Research Buy
2022-06-30 Eingeleitet H.C. Wainwright Buy
2022-01-21 Hochstufung BofA Securities Neutral → Buy
2021-07-26 Eingeleitet BofA Securities Neutral
2021-07-26 Eingeleitet Credit Suisse Outperform
2021-07-26 Eingeleitet Stifel Buy
2021-07-26 Eingeleitet UBS Buy
Alle ansehen

Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten

pulisher
05:46 AM

Long term hold vs stop loss in Acumen Pharmaceuticals Inc.2025 Earnings Surprises & AI Driven Price Predictions - newser.com

05:46 AM
pulisher
05:24 AM

Relative strength of Acumen Pharmaceuticals Inc. in sector analysisJuly 2025 Momentum & Fast Gain Swing Alerts - newser.com

05:24 AM
pulisher
04:08 AM

Tools to monitor Acumen Pharmaceuticals Inc. recovery probabilityJuly 2025 Setups & Step-by-Step Trade Execution Guides - newser.com

04:08 AM
pulisher
Oct 13, 2025

Acumen Pharmaceuticals Inc. stock retracement – recovery analysisTrade Analysis Summary & Weekly Top Performers Watchlists - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

What to do if you’re stuck in Acumen Pharmaceuticals Inc.2025 Price Momentum & Target Return Focused Stock Picks - newser.com

Oct 13, 2025
pulisher
Oct 10, 2025

What the charts say about Acumen Pharmaceuticals Inc. todayQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Acumen Pharmaceuticals Inc. stock a top pick in earnings season2025 Winners & Losers & Low Risk Investment Opportunities - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

How Acumen Pharmaceuticals Inc. stock reacts to oil prices2025 Retail Activity & Free Real-Time Market Sentiment Alerts - newser.com

Oct 09, 2025
pulisher
Oct 08, 2025

Central Nervous System Biomarkers Market Growth & Industry - openPR.com

Oct 08, 2025
pulisher
Oct 06, 2025

What analysts say about Acumen Pharmaceuticals Inc stockMomentum Trading Signals & Stay One Step Ahead of Risk Events - earlytimes.in

Oct 06, 2025
pulisher
Oct 06, 2025

Institutional scanner results for Acumen Pharmaceuticals Inc.Quarterly Profit Report & Risk Managed Investment Entry Signals - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Trend analysis for Acumen Pharmaceuticals Inc. this weekWeekly Profit Recap & AI Driven Price Forecasts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Published on: 2025-10-05 05:00:14 - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Will Acumen Pharmaceuticals Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Safe Swing Trade Setup Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Is it time to cut losses on Acumen Pharmaceuticals Inc.July 2025 Trends & Verified Momentum Watchlists - newser.com

Oct 05, 2025
pulisher
Sep 30, 2025

Promising Penny Stocks To Watch In September 2025 - Yahoo Finance

Sep 30, 2025
pulisher
Sep 30, 2025

Analyzing net buyer seller activity in Acumen Pharmaceuticals Inc.July 2025 Setups & AI Powered Market Entry Ideas - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Is Acumen Pharmaceuticals Inc a good long term investmentHigh Dividend Yield Stocks & Outstanding Capital Tips - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

Acumen Pharmaceuticals, Inc. $ABOS Shares Sold by Goldman Sachs Group Inc. - Defense World

Sep 29, 2025

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Acumen Pharmaceuticals Inc-Aktie (ABOS) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Zuga Matt
CFO & Chief Business Officer
Jan 21 '25
Sale
1.60
4,364
6,986
260,646
OConnell Daniel Joseph
Chief Executive Officer
Jan 21 '25
Sale
1.59
12,619
20,102
667,488
Meisner Derek M
Chief Legal Officer & Corp Sec
Jan 21 '25
Sale
1.59
3,418
5,435
161,127
Barton Russell
Chief Operating Officer
Jan 21 '25
Sale
1.61
2,914
4,692
136,117
Siemers Eric
Chief Medical Officer
Jan 21 '25
Sale
1.59
3,219
5,118
170,298
$21.75
price down icon 5.47%
$85.96
price up icon 1.59%
$32.75
price up icon 0.41%
$102.61
price up icon 0.29%
$161.38
price down icon 1.45%
biotechnology ONC
$320.94
price down icon 1.85%
Kapitalisierung:     |  Volumen (24h):